nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—SLC28A3—Gemcitabine—lung cancer	0.295	1	CbGbCtD
Adenosine—Cytarabine—Gemcitabine—lung cancer	0.158	0.35	CrCrCtD
Adenosine—Azacitidine—Gemcitabine—lung cancer	0.15	0.333	CrCrCtD
Adenosine—Decitabine—Gemcitabine—lung cancer	0.143	0.317	CrCrCtD
Adenosine—ADA—pleura—lung cancer	0.0218	0.368	CbGeAlD
Adenosine—SLC28A3—respiratory system—lung cancer	0.00332	0.0561	CbGeAlD
Adenosine—ADK—mammary gland—lung cancer	0.00265	0.0448	CbGeAlD
Adenosine—SLC28A3—trachea—lung cancer	0.00245	0.0414	CbGeAlD
Adenosine—ADA—respiratory system—lung cancer	0.00216	0.0365	CbGeAlD
Adenosine—ADORA2B—bronchus—lung cancer	0.00194	0.0329	CbGeAlD
Adenosine—SLC28A3—bone marrow—lung cancer	0.00194	0.0329	CbGeAlD
Adenosine—SLC28A3—lung—lung cancer	0.00176	0.0298	CbGeAlD
Adenosine—ADORA2B—trachea—lung cancer	0.00175	0.0295	CbGeAlD
Adenosine—DPP4—respiratory system—lung cancer	0.00171	0.0289	CbGeAlD
Adenosine—ADK—bronchus—lung cancer	0.00145	0.0246	CbGeAlD
Adenosine—DPP4—epithelium—lung cancer	0.00143	0.0242	CbGeAlD
Adenosine—ADK—trachea—lung cancer	0.0013	0.0221	CbGeAlD
Adenosine—ADA—bone marrow—lung cancer	0.00127	0.0214	CbGeAlD
Adenosine—ADORA2B—lung—lung cancer	0.00125	0.0212	CbGeAlD
Adenosine—ADK—cardiac atrium—lung cancer	0.00123	0.0207	CbGeAlD
Adenosine—ADORA1—cardiac atrium—lung cancer	0.00118	0.0199	CbGeAlD
Adenosine—ADA—lung—lung cancer	0.00115	0.0194	CbGeAlD
Adenosine—Adenosine monophosphate—ADCY1—lung cancer	0.00104	0.176	CrCbGaD
Adenosine—ADK—bone marrow—lung cancer	0.00103	0.0175	CbGeAlD
Adenosine—DPP4—bone marrow—lung cancer	0.001	0.017	CbGeAlD
Adenosine—ADK—lung—lung cancer	0.000938	0.0159	CbGeAlD
Adenosine—DPP4—lung—lung cancer	0.000909	0.0154	CbGeAlD
Adenosine—ADORA1—lung—lung cancer	0.000901	0.0152	CbGeAlD
Adenosine—Adenosine triphosphate—ADCY1—lung cancer	0.0009	0.152	CrCbGaD
Adenosine—Clofarabine—RRM1—lung cancer	0.000823	0.139	CrCbGaD
Adenosine—Fludarabine—RRM1—lung cancer	0.000797	0.135	CrCbGaD
Adenosine—ADA—lymph node—lung cancer	0.000785	0.0133	CbGeAlD
Adenosine—ADK—lymph node—lung cancer	0.000641	0.0108	CbGeAlD
Adenosine—DPP4—lymph node—lung cancer	0.000622	0.0105	CbGeAlD
Adenosine—ADORA1—lymph node—lung cancer	0.000617	0.0104	CbGeAlD
Adenosine—Cladribine—RRM1—lung cancer	0.000473	0.08	CrCbGaD
Adenosine—Glucosamine—MMP9—lung cancer	0.00038	0.0643	CrCbGaD
Adenosine—Adenosine triphosphate—ALK—lung cancer	0.000313	0.053	CrCbGaD
Adenosine—Adenosine triphosphate—AKT1—lung cancer	0.000244	0.0414	CrCbGaD
Adenosine—Adenosine monophosphate—SRC—lung cancer	0.000241	0.0408	CrCbGaD
Adenosine—Clofarabine—ABCG2—lung cancer	0.00021	0.0356	CrCbGaD
Adenosine—Glucosamine—CYP2E1—lung cancer	0.000192	0.0326	CrCbGaD
Adenosine—Chest pain—Gemcitabine—lung cancer	0.000148	0.00124	CcSEcCtD
Adenosine—Asthenia—Erlotinib—lung cancer	0.000146	0.00123	CcSEcCtD
Adenosine—Discomfort—Gemcitabine—lung cancer	0.000146	0.00123	CcSEcCtD
Adenosine—Anaphylactic shock—Irinotecan—lung cancer	0.000145	0.00122	CcSEcCtD
Adenosine—Dysgeusia—Etoposide—lung cancer	0.000145	0.00122	CcSEcCtD
Adenosine—Back pain—Etoposide—lung cancer	0.000143	0.00121	CcSEcCtD
Adenosine—Shock—Irinotecan—lung cancer	0.000143	0.0012	CcSEcCtD
Adenosine—Tension—Paclitaxel—lung cancer	0.000142	0.0012	CcSEcCtD
Adenosine—Dysgeusia—Paclitaxel—lung cancer	0.000142	0.0012	CcSEcCtD
Adenosine—Anaphylactic shock—Gemcitabine—lung cancer	0.000141	0.00119	CcSEcCtD
Adenosine—Nervousness—Paclitaxel—lung cancer	0.000141	0.00119	CcSEcCtD
Adenosine—Hypoaesthesia—Docetaxel—lung cancer	0.000141	0.00119	CcSEcCtD
Adenosine—Hyperhidrosis—Irinotecan—lung cancer	0.00014	0.00118	CcSEcCtD
Adenosine—Back pain—Paclitaxel—lung cancer	0.00014	0.00118	CcSEcCtD
Adenosine—Dizziness—Vinblastine—lung cancer	0.00014	0.00118	CcSEcCtD
Adenosine—Convulsion—Cisplatin—lung cancer	0.00014	0.00118	CcSEcCtD
Adenosine—Urticaria—Vinorelbine—lung cancer	0.00014	0.00118	CcSEcCtD
Adenosine—Mood swings—Methotrexate—lung cancer	0.000139	0.00118	CcSEcCtD
Adenosine—Anxiety—Cisplatin—lung cancer	0.000137	0.00116	CcSEcCtD
Adenosine—Vision blurred—Paclitaxel—lung cancer	0.000137	0.00115	CcSEcCtD
Adenosine—Hyperhidrosis—Gemcitabine—lung cancer	0.000137	0.00115	CcSEcCtD
Adenosine—Dizziness—Topotecan—lung cancer	0.000136	0.00115	CcSEcCtD
Adenosine—Tremor—Paclitaxel—lung cancer	0.000136	0.00115	CcSEcCtD
Adenosine—Discomfort—Cisplatin—lung cancer	0.000136	0.00115	CcSEcCtD
Adenosine—Hypotension—Irinotecan—lung cancer	0.000136	0.00114	CcSEcCtD
Adenosine—Vomiting—Vinblastine—lung cancer	0.000135	0.00114	CcSEcCtD
Adenosine—Dizziness—Erlotinib—lung cancer	0.000135	0.00114	CcSEcCtD
Adenosine—Agitation—Paclitaxel—lung cancer	0.000133	0.00112	CcSEcCtD
Adenosine—Headache—Vinblastine—lung cancer	0.000133	0.00112	CcSEcCtD
Adenosine—Angioedema—Paclitaxel—lung cancer	0.000133	0.00112	CcSEcCtD
Adenosine—Hypotension—Gemcitabine—lung cancer	0.000132	0.00111	CcSEcCtD
Adenosine—Anaphylactic shock—Cisplatin—lung cancer	0.000132	0.00111	CcSEcCtD
Adenosine—S-Adenosylmethionine—CYP2E1—lung cancer	0.000132	0.0223	CrCbGaD
Adenosine—Flushing—Docetaxel—lung cancer	0.000131	0.00111	CcSEcCtD
Adenosine—Cardiac disorder—Docetaxel—lung cancer	0.000131	0.00111	CcSEcCtD
Adenosine—Vomiting—Topotecan—lung cancer	0.000131	0.0011	CcSEcCtD
Adenosine—Cardiac failure—Doxorubicin—lung cancer	0.000131	0.0011	CcSEcCtD
Adenosine—Paraesthesia—Irinotecan—lung cancer	0.00013	0.0011	CcSEcCtD
Adenosine—Syncope—Paclitaxel—lung cancer	0.00013	0.0011	CcSEcCtD
Adenosine—Loss of consciousness—Etoposide—lung cancer	0.00013	0.0011	CcSEcCtD
Adenosine—Cerebrovascular accident—Doxorubicin—lung cancer	0.00013	0.0011	CcSEcCtD
Adenosine—Rash—Topotecan—lung cancer	0.00013	0.00109	CcSEcCtD
Adenosine—Hypersensitivity—Vinorelbine—lung cancer	0.00013	0.00109	CcSEcCtD
Adenosine—Dermatitis—Topotecan—lung cancer	0.00013	0.00109	CcSEcCtD
Adenosine—Vomiting—Erlotinib—lung cancer	0.00013	0.00109	CcSEcCtD
Adenosine—Dyspnoea—Irinotecan—lung cancer	0.000129	0.00109	CcSEcCtD
Adenosine—Cough—Etoposide—lung cancer	0.000129	0.00109	CcSEcCtD
Adenosine—Somnolence—Irinotecan—lung cancer	0.000129	0.00109	CcSEcCtD
Adenosine—Headache—Topotecan—lung cancer	0.000129	0.00109	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000129	0.00109	CcSEcCtD
Adenosine—Tachycardia—Cisplatin—lung cancer	0.000129	0.00109	CcSEcCtD
Adenosine—Rash—Erlotinib—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Dermatitis—Erlotinib—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Palpitations—Paclitaxel—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Convulsion—Etoposide—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Hypertension—Etoposide—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Headache—Erlotinib—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Loss of consciousness—Paclitaxel—lung cancer	0.000128	0.00108	CcSEcCtD
Adenosine—Hyperhidrosis—Cisplatin—lung cancer	0.000127	0.00107	CcSEcCtD
Adenosine—Mediastinal disorder—Docetaxel—lung cancer	0.000127	0.00107	CcSEcCtD
Adenosine—Paraesthesia—Gemcitabine—lung cancer	0.000127	0.00107	CcSEcCtD
Adenosine—Cough—Paclitaxel—lung cancer	0.000127	0.00107	CcSEcCtD
Adenosine—Asthenia—Vinorelbine—lung cancer	0.000126	0.00107	CcSEcCtD
Adenosine—Arrhythmia—Docetaxel—lung cancer	0.000126	0.00106	CcSEcCtD
Adenosine—Dyspnoea—Gemcitabine—lung cancer	0.000126	0.00106	CcSEcCtD
Adenosine—Chest pain—Etoposide—lung cancer	0.000126	0.00106	CcSEcCtD
Adenosine—Nausea—Vinblastine—lung cancer	0.000126	0.00106	CcSEcCtD
Adenosine—Somnolence—Gemcitabine—lung cancer	0.000126	0.00106	CcSEcCtD
Adenosine—Convulsion—Paclitaxel—lung cancer	0.000126	0.00106	CcSEcCtD
Adenosine—Affect lability—Doxorubicin—lung cancer	0.000125	0.00106	CcSEcCtD
Adenosine—Hypertension—Paclitaxel—lung cancer	0.000125	0.00106	CcSEcCtD
Adenosine—Discomfort—Etoposide—lung cancer	0.000125	0.00105	CcSEcCtD
Adenosine—Pain—Irinotecan—lung cancer	0.000124	0.00105	CcSEcCtD
Adenosine—Chest pain—Paclitaxel—lung cancer	0.000124	0.00104	CcSEcCtD
Adenosine—Hypotension—Cisplatin—lung cancer	0.000123	0.00104	CcSEcCtD
Adenosine—Anxiety—Paclitaxel—lung cancer	0.000123	0.00104	CcSEcCtD
Adenosine—Nausea—Topotecan—lung cancer	0.000122	0.00103	CcSEcCtD
Adenosine—Discomfort—Paclitaxel—lung cancer	0.000122	0.00103	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—lung cancer	0.000122	0.00103	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—lung cancer	0.000121	0.00102	CcSEcCtD
Adenosine—Pain—Gemcitabine—lung cancer	0.000121	0.00102	CcSEcCtD
Adenosine—Nausea—Erlotinib—lung cancer	0.000121	0.00102	CcSEcCtD
Adenosine—Dry mouth—Paclitaxel—lung cancer	0.000121	0.00102	CcSEcCtD
Adenosine—Anaphylactic shock—Etoposide—lung cancer	0.000121	0.00102	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—lung cancer	0.000121	0.00102	CcSEcCtD
Adenosine—Cladribine—ABCG2—lung cancer	0.000121	0.0204	CrCbGaD
Adenosine—Dysgeusia—Docetaxel—lung cancer	0.00012	0.00102	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00012	0.00101	CcSEcCtD
Adenosine—Back pain—Docetaxel—lung cancer	0.000119	0.001	CcSEcCtD
Adenosine—Anaphylactic shock—Paclitaxel—lung cancer	0.000118	0.000999	CcSEcCtD
Adenosine—Paraesthesia—Cisplatin—lung cancer	0.000118	0.000998	CcSEcCtD
Adenosine—Tachycardia—Etoposide—lung cancer	0.000118	0.000994	CcSEcCtD
Adenosine—Dyspnoea—Cisplatin—lung cancer	0.000118	0.000991	CcSEcCtD
Adenosine—Hyperhidrosis—Etoposide—lung cancer	0.000117	0.000985	CcSEcCtD
Adenosine—Shock—Paclitaxel—lung cancer	0.000117	0.000983	CcSEcCtD
Adenosine—Dizziness—Vinorelbine—lung cancer	0.000116	0.000982	CcSEcCtD
Adenosine—Tachycardia—Paclitaxel—lung cancer	0.000116	0.000975	CcSEcCtD
Adenosine—Hyperhidrosis—Paclitaxel—lung cancer	0.000115	0.000965	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—lung cancer	0.000113	0.000957	CcSEcCtD
Adenosine—Hypotension—Etoposide—lung cancer	0.000113	0.000952	CcSEcCtD
Adenosine—Pain—Cisplatin—lung cancer	0.000113	0.000951	CcSEcCtD
Adenosine—Vomiting—Vinorelbine—lung cancer	0.000112	0.000944	CcSEcCtD
Adenosine—Rash—Vinorelbine—lung cancer	0.000111	0.000936	CcSEcCtD
Adenosine—Dermatitis—Vinorelbine—lung cancer	0.000111	0.000935	CcSEcCtD
Adenosine—Hypotension—Paclitaxel—lung cancer	0.000111	0.000933	CcSEcCtD
Adenosine—Headache—Vinorelbine—lung cancer	0.00011	0.00093	CcSEcCtD
Adenosine—Syncope—Docetaxel—lung cancer	0.00011	0.00093	CcSEcCtD
Adenosine—Sweating—Methotrexate—lung cancer	0.000109	0.000917	CcSEcCtD
Adenosine—Palpitations—Docetaxel—lung cancer	0.000109	0.000917	CcSEcCtD
Adenosine—Paraesthesia—Etoposide—lung cancer	0.000108	0.000915	CcSEcCtD
Adenosine—Loss of consciousness—Docetaxel—lung cancer	0.000108	0.000912	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000108	0.00091	CcSEcCtD
Adenosine—Dyspnoea—Etoposide—lung cancer	0.000108	0.000908	CcSEcCtD
Adenosine—Somnolence—Etoposide—lung cancer	0.000107	0.000906	CcSEcCtD
Adenosine—Cough—Docetaxel—lung cancer	0.000107	0.000905	CcSEcCtD
Adenosine—Hypersensitivity—Irinotecan—lung cancer	0.000107	0.000902	CcSEcCtD
Adenosine—Convulsion—Docetaxel—lung cancer	0.000107	0.000899	CcSEcCtD
Adenosine—Paraesthesia—Paclitaxel—lung cancer	0.000106	0.000897	CcSEcCtD
Adenosine—Hypertension—Docetaxel—lung cancer	0.000106	0.000895	CcSEcCtD
Adenosine—Dyspnoea—Paclitaxel—lung cancer	0.000106	0.00089	CcSEcCtD
Adenosine—Somnolence—Paclitaxel—lung cancer	0.000105	0.000888	CcSEcCtD
Adenosine—Chest pain—Docetaxel—lung cancer	0.000105	0.000883	CcSEcCtD
Adenosine—Nausea—Vinorelbine—lung cancer	0.000105	0.000882	CcSEcCtD
Adenosine—Asthenia—Irinotecan—lung cancer	0.000104	0.000879	CcSEcCtD
Adenosine—Pain—Etoposide—lung cancer	0.000103	0.000871	CcSEcCtD
Adenosine—Dry mouth—Docetaxel—lung cancer	0.000102	0.000864	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—lung cancer	0.000102	0.000858	CcSEcCtD
Adenosine—Asthenia—Gemcitabine—lung cancer	0.000102	0.000856	CcSEcCtD
Adenosine—Pain—Paclitaxel—lung cancer	0.000101	0.000854	CcSEcCtD
Adenosine—Anaphylactic shock—Docetaxel—lung cancer	0.0001	0.000846	CcSEcCtD
Adenosine—Shock—Docetaxel—lung cancer	9.88e-05	0.000833	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—lung cancer	9.82e-05	0.000828	CcSEcCtD
Adenosine—Tachycardia—Docetaxel—lung cancer	9.8e-05	0.000826	CcSEcCtD
Adenosine—Hypersensitivity—Cisplatin—lung cancer	9.72e-05	0.000819	CcSEcCtD
Adenosine—Dizziness—Irinotecan—lung cancer	9.6e-05	0.00081	CcSEcCtD
Adenosine—Urticaria—Etoposide—lung cancer	9.6e-05	0.000809	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—lung cancer	9.5e-05	0.000801	CcSEcCtD
Adenosine—Asthenia—Cisplatin—lung cancer	9.46e-05	0.000798	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—lung cancer	9.45e-05	0.000797	CcSEcCtD
Adenosine—Sweating—Doxorubicin—lung cancer	9.42e-05	0.000794	CcSEcCtD
Adenosine—Urticaria—Paclitaxel—lung cancer	9.41e-05	0.000793	CcSEcCtD
Adenosine—Hypotension—Docetaxel—lung cancer	9.38e-05	0.000791	CcSEcCtD
Adenosine—Vomiting—Irinotecan—lung cancer	9.23e-05	0.000779	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—lung cancer	9.18e-05	0.000774	CcSEcCtD
Adenosine—Rash—Irinotecan—lung cancer	9.16e-05	0.000772	CcSEcCtD
Adenosine—Dermatitis—Irinotecan—lung cancer	9.15e-05	0.000771	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Docetaxel—lung cancer	9.15e-05	0.000771	CcSEcCtD
Adenosine—Headache—Irinotecan—lung cancer	9.1e-05	0.000767	CcSEcCtD
Adenosine—Paraesthesia—Docetaxel—lung cancer	9.02e-05	0.00076	CcSEcCtD
Adenosine—Vomiting—Gemcitabine—lung cancer	9e-05	0.000758	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—lung cancer	8.98e-05	0.000757	CcSEcCtD
Adenosine—Dyspnoea—Docetaxel—lung cancer	8.95e-05	0.000755	CcSEcCtD
Adenosine—Somnolence—Docetaxel—lung cancer	8.93e-05	0.000753	CcSEcCtD
Adenosine—Rash—Gemcitabine—lung cancer	8.92e-05	0.000752	CcSEcCtD
Adenosine—Dermatitis—Gemcitabine—lung cancer	8.91e-05	0.000751	CcSEcCtD
Adenosine—Hypersensitivity—Etoposide—lung cancer	8.9e-05	0.00075	CcSEcCtD
Adenosine—Headache—Gemcitabine—lung cancer	8.86e-05	0.000747	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—lung cancer	8.78e-05	0.00074	CcSEcCtD
Adenosine—Hypersensitivity—Paclitaxel—lung cancer	8.73e-05	0.000736	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—lung cancer	8.68e-05	0.000732	CcSEcCtD
Adenosine—Asthenia—Etoposide—lung cancer	8.67e-05	0.000731	CcSEcCtD
Adenosine—Nausea—Irinotecan—lung cancer	8.63e-05	0.000727	CcSEcCtD
Adenosine—Pain—Docetaxel—lung cancer	8.59e-05	0.000724	CcSEcCtD
Adenosine—Back pain—Methotrexate—lung cancer	8.58e-05	0.000723	CcSEcCtD
Adenosine—Asthenia—Paclitaxel—lung cancer	8.5e-05	0.000717	CcSEcCtD
Adenosine—Nausea—Gemcitabine—lung cancer	8.4e-05	0.000709	CcSEcCtD
Adenosine—Vomiting—Cisplatin—lung cancer	8.38e-05	0.000707	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—lung cancer	8.36e-05	0.000705	CcSEcCtD
Adenosine—Rash—Cisplatin—lung cancer	8.31e-05	0.000701	CcSEcCtD
Adenosine—Dermatitis—Cisplatin—lung cancer	8.31e-05	0.0007	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—lung cancer	8.22e-05	0.000693	CcSEcCtD
Adenosine—Flushing—Doxorubicin—lung cancer	8.19e-05	0.00069	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—lung cancer	8.19e-05	0.00069	CcSEcCtD
Adenosine—Dizziness—Etoposide—lung cancer	7.99e-05	0.000674	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—lung cancer	7.95e-05	0.00067	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—lung cancer	7.88e-05	0.000664	CcSEcCtD
Adenosine—Dizziness—Paclitaxel—lung cancer	7.83e-05	0.00066	CcSEcCtD
Adenosine—Nausea—Cisplatin—lung cancer	7.83e-05	0.00066	CcSEcCtD
Adenosine—Cough—Methotrexate—lung cancer	7.74e-05	0.000652	CcSEcCtD
Adenosine—Convulsion—Methotrexate—lung cancer	7.68e-05	0.000648	CcSEcCtD
Adenosine—Vomiting—Etoposide—lung cancer	7.68e-05	0.000648	CcSEcCtD
Adenosine—Rash—Etoposide—lung cancer	7.62e-05	0.000642	CcSEcCtD
Adenosine—Dermatitis—Etoposide—lung cancer	7.61e-05	0.000642	CcSEcCtD
Adenosine—Headache—Etoposide—lung cancer	7.57e-05	0.000638	CcSEcCtD
Adenosine—Chest pain—Methotrexate—lung cancer	7.55e-05	0.000636	CcSEcCtD
Adenosine—Tension—Doxorubicin—lung cancer	7.53e-05	0.000635	CcSEcCtD
Adenosine—Vomiting—Paclitaxel—lung cancer	7.53e-05	0.000635	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—lung cancer	7.52e-05	0.000634	CcSEcCtD
Adenosine—Rash—Paclitaxel—lung cancer	7.47e-05	0.00063	CcSEcCtD
Adenosine—Dermatitis—Paclitaxel—lung cancer	7.46e-05	0.000629	CcSEcCtD
Adenosine—Discomfort—Methotrexate—lung cancer	7.46e-05	0.000629	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—lung cancer	7.46e-05	0.000629	CcSEcCtD
Adenosine—Back pain—Doxorubicin—lung cancer	7.43e-05	0.000626	CcSEcCtD
Adenosine—Headache—Paclitaxel—lung cancer	7.42e-05	0.000626	CcSEcCtD
Adenosine—Hypersensitivity—Docetaxel—lung cancer	7.4e-05	0.000624	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—lung cancer	7.24e-05	0.00061	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—lung cancer	7.24e-05	0.00061	CcSEcCtD
Adenosine—Asthenia—Docetaxel—lung cancer	7.2e-05	0.000607	CcSEcCtD
Adenosine—Nausea—Etoposide—lung cancer	7.18e-05	0.000605	CcSEcCtD
Adenosine—Agitation—Doxorubicin—lung cancer	7.06e-05	0.000595	CcSEcCtD
Adenosine—Nausea—Paclitaxel—lung cancer	7.04e-05	0.000593	CcSEcCtD
Adenosine—Hyperhidrosis—Methotrexate—lung cancer	7e-05	0.00059	CcSEcCtD
Adenosine—Syncope—Doxorubicin—lung cancer	6.89e-05	0.00058	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—lung cancer	6.78e-05	0.000572	CcSEcCtD
Adenosine—Hypotension—Methotrexate—lung cancer	6.76e-05	0.00057	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—lung cancer	6.75e-05	0.000569	CcSEcCtD
Adenosine—Cough—Doxorubicin—lung cancer	6.7e-05	0.000565	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—lung cancer	6.65e-05	0.000561	CcSEcCtD
Adenosine—Dizziness—Docetaxel—lung cancer	6.64e-05	0.00056	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—lung cancer	6.63e-05	0.000559	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—lung cancer	6.59e-05	0.000556	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—lung cancer	6.54e-05	0.000551	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—lung cancer	6.51e-05	0.000549	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—lung cancer	6.5e-05	0.000548	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—lung cancer	6.46e-05	0.000544	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—lung cancer	6.45e-05	0.000544	CcSEcCtD
Adenosine—Somnolence—Methotrexate—lung cancer	6.43e-05	0.000542	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—lung cancer	6.39e-05	0.000539	CcSEcCtD
Adenosine—Vomiting—Docetaxel—lung cancer	6.38e-05	0.000538	CcSEcCtD
Adenosine—Rash—Docetaxel—lung cancer	6.33e-05	0.000534	CcSEcCtD
Adenosine—Dermatitis—Docetaxel—lung cancer	6.32e-05	0.000533	CcSEcCtD
Adenosine—Headache—Docetaxel—lung cancer	6.29e-05	0.00053	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—lung cancer	6.27e-05	0.000528	CcSEcCtD
Adenosine—Pain—Methotrexate—lung cancer	6.19e-05	0.000522	CcSEcCtD
Adenosine—Shock—Doxorubicin—lung cancer	6.16e-05	0.00052	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—lung cancer	6.12e-05	0.000516	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—lung cancer	6.06e-05	0.000511	CcSEcCtD
Adenosine—Nausea—Docetaxel—lung cancer	5.96e-05	0.000503	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—lung cancer	5.86e-05	0.000494	CcSEcCtD
Adenosine—Urticaria—Methotrexate—lung cancer	5.75e-05	0.000485	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.71e-05	0.000481	CcSEcCtD
Adenosine—Paraesthesia—Doxorubicin—lung cancer	5.63e-05	0.000474	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—lung cancer	5.59e-05	0.000471	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—lung cancer	5.57e-05	0.00047	CcSEcCtD
Adenosine—Pain—Doxorubicin—lung cancer	5.36e-05	0.000452	CcSEcCtD
Adenosine—Hypersensitivity—Methotrexate—lung cancer	5.33e-05	0.000449	CcSEcCtD
Adenosine—Asthenia—Methotrexate—lung cancer	5.19e-05	0.000438	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—lung cancer	4.98e-05	0.00042	CcSEcCtD
Adenosine—Dizziness—Methotrexate—lung cancer	4.79e-05	0.000403	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—lung cancer	4.62e-05	0.000389	CcSEcCtD
Adenosine—Vomiting—Methotrexate—lung cancer	4.6e-05	0.000388	CcSEcCtD
Adenosine—Rash—Methotrexate—lung cancer	4.56e-05	0.000385	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—lung cancer	4.56e-05	0.000384	CcSEcCtD
Adenosine—Headache—Methotrexate—lung cancer	4.53e-05	0.000382	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—lung cancer	4.5e-05	0.000379	CcSEcCtD
Adenosine—Nausea—Methotrexate—lung cancer	4.3e-05	0.000362	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—lung cancer	4.27e-05	0.00723	CrCbGaD
Adenosine—Dizziness—Doxorubicin—lung cancer	4.14e-05	0.000349	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—lung cancer	3.98e-05	0.000336	CcSEcCtD
Adenosine—Rash—Doxorubicin—lung cancer	3.95e-05	0.000333	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—lung cancer	3.95e-05	0.000333	CcSEcCtD
Adenosine—Headache—Doxorubicin—lung cancer	3.93e-05	0.000331	CcSEcCtD
Adenosine—Nausea—Doxorubicin—lung cancer	3.72e-05	0.000314	CcSEcCtD
Adenosine—ADORA1—Signaling Pathways—APP—lung cancer	2.32e-05	0.000328	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KRAS—lung cancer	2.3e-05	0.000325	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGF9—lung cancer	2.3e-05	0.000325	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFC—lung cancer	2.28e-05	0.000323	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CB—lung cancer	2.28e-05	0.000323	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FOXO3—lung cancer	2.26e-05	0.00032	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTGS2—lung cancer	2.26e-05	0.00032	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—lung cancer	2.24e-05	0.000317	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—POMC—lung cancer	2.23e-05	0.000316	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAP2K1—lung cancer	2.21e-05	0.000314	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOA1—lung cancer	2.21e-05	0.000313	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CD—lung cancer	2.2e-05	0.000312	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUNB—lung cancer	2.19e-05	0.00031	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADCY1—lung cancer	2.16e-05	0.000305	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CG—lung cancer	2.13e-05	0.000301	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AVP—lung cancer	2.12e-05	0.0003	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CB—lung cancer	2.11e-05	0.000299	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—PIK3CA—lung cancer	2.11e-05	0.000299	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PPP2R1B—lung cancer	2.1e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMARCA4—lung cancer	2.1e-05	0.000298	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CD—lung cancer	2.06e-05	0.000292	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1R—lung cancer	2.04e-05	0.000289	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—lung cancer	2.03e-05	0.000287	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HSPB1—lung cancer	2.03e-05	0.000287	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—POMC—lung cancer	2.03e-05	0.000287	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CG—lung cancer	2.02e-05	0.000286	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTHLH—lung cancer	2.01e-05	0.000284	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HES1—lung cancer	2e-05	0.000284	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STK11—lung cancer	1.99e-05	0.000282	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6R—lung cancer	1.98e-05	0.00028	CbGpPWpGaD
Adenosine—ADK—Metabolism—PTEN—lung cancer	1.97e-05	0.000279	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—RAF1—lung cancer	1.96e-05	0.000278	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HRAS—lung cancer	1.95e-05	0.000277	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—lung cancer	1.94e-05	0.000275	CbGpPWpGaD
Adenosine—ADA—Metabolism—POMC—lung cancer	1.92e-05	0.000272	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FOXO3—lung cancer	1.92e-05	0.000272	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CB—lung cancer	1.92e-05	0.000272	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ANXA1—lung cancer	1.89e-05	0.000267	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAP2K1—lung cancer	1.88e-05	0.000267	CbGpPWpGaD
Adenosine—ADK—Metabolism—EP300—lung cancer	1.88e-05	0.000266	CbGpPWpGaD
Adenosine—ADA—Metabolism—CREBBP—lung cancer	1.87e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CD—lung cancer	1.87e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—lung cancer	1.87e-05	0.000265	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—lung cancer	1.84e-05	0.000261	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB3—lung cancer	1.83e-05	0.000259	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FLT1—lung cancer	1.83e-05	0.000259	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CG—lung cancer	1.81e-05	0.000256	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AVP—lung cancer	1.8e-05	0.000255	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CB—lung cancer	1.8e-05	0.000254	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH3—lung cancer	1.79e-05	0.000253	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APP—lung cancer	1.79e-05	0.000253	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CD—lung cancer	1.78e-05	0.000252	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF9—lung cancer	1.77e-05	0.000251	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—lung cancer	1.76e-05	0.000249	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TERT—lung cancer	1.75e-05	0.000248	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—lung cancer	1.75e-05	0.000248	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—lung cancer	1.73e-05	0.000245	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—lung cancer	1.73e-05	0.000244	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—lung cancer	1.72e-05	0.000244	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—POMC—lung cancer	1.72e-05	0.000244	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGFR1—lung cancer	1.7e-05	0.000241	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HES1—lung cancer	1.7e-05	0.000241	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUNB—lung cancer	1.69e-05	0.00024	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—lung cancer	1.68e-05	0.000238	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RAF1—lung cancer	1.67e-05	0.000236	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—lung cancer	1.65e-05	0.000234	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CG—lung cancer	1.64e-05	0.000233	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CB—lung cancer	1.63e-05	0.000231	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOA1—lung cancer	1.62e-05	0.000229	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—lung cancer	1.6e-05	0.000227	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CD—lung cancer	1.59e-05	0.000225	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—lung cancer	1.57e-05	0.000222	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—POMC—lung cancer	1.56e-05	0.000221	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB3—lung cancer	1.56e-05	0.00022	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CB—lung cancer	1.55e-05	0.000219	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STK11—lung cancer	1.54e-05	0.000218	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—lung cancer	1.53e-05	0.000217	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6R—lung cancer	1.53e-05	0.000216	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—lung cancer	1.5e-05	0.000212	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TERT—lung cancer	1.49e-05	0.000211	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FOXO3—lung cancer	1.48e-05	0.00021	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APC—lung cancer	1.48e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CG—lung cancer	1.48e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KIT—lung cancer	1.48e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—NRAS—lung cancer	1.48e-05	0.000209	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGF—lung cancer	1.46e-05	0.000207	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAP2K1—lung cancer	1.45e-05	0.000206	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR1—lung cancer	1.45e-05	0.000205	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CD—lung cancer	1.44e-05	0.000205	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—lung cancer	1.43e-05	0.000202	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK3—lung cancer	1.42e-05	0.0002	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—POMC—lung cancer	1.41e-05	0.000199	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AVP—lung cancer	1.39e-05	0.000197	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BRAF—lung cancer	1.39e-05	0.000197	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—lung cancer	1.39e-05	0.000197	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CB—lung cancer	1.39e-05	0.000196	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOA1—lung cancer	1.38e-05	0.000195	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6R—lung cancer	1.37e-05	0.000194	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CREBBP—lung cancer	1.37e-05	0.000194	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—lung cancer	1.36e-05	0.000193	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—lung cancer	1.35e-05	0.000191	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—lung cancer	1.34e-05	0.000189	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—lung cancer	1.34e-05	0.000189	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—lung cancer	1.33e-05	0.000189	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HES1—lung cancer	1.31e-05	0.000186	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAP2K1—lung cancer	1.31e-05	0.000185	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CD—lung cancer	1.3e-05	0.000184	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RAF1—lung cancer	1.29e-05	0.000183	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—lung cancer	1.29e-05	0.000182	CbGpPWpGaD
Adenosine—ADA—Metabolism—EP300—lung cancer	1.28e-05	0.000181	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—lung cancer	1.27e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—lung cancer	1.27e-05	0.00018	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CB—lung cancer	1.26e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APC—lung cancer	1.26e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CG—lung cancer	1.26e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KIT—lung cancer	1.26e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—NRAS—lung cancer	1.26e-05	0.000178	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGF—lung cancer	1.24e-05	0.000176	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—lung cancer	1.21e-05	0.000171	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK3—lung cancer	1.2e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB3—lung cancer	1.2e-05	0.00017	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—POMC—lung cancer	1.2e-05	0.000169	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BRAF—lung cancer	1.18e-05	0.000167	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—lung cancer	1.17e-05	0.000166	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6R—lung cancer	1.17e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CREBBP—lung cancer	1.17e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MDM2—lung cancer	1.16e-05	0.000165	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RAF1—lung cancer	1.16e-05	0.000164	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—lung cancer	1.16e-05	0.000164	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TERT—lung cancer	1.15e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—lung cancer	1.15e-05	0.000163	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—lung cancer	1.15e-05	0.000162	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—lung cancer	1.13e-05	0.000161	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MTOR—lung cancer	1.13e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CB—lung cancer	1.13e-05	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR1—lung cancer	1.12e-05	0.000158	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAP2K1—lung cancer	1.11e-05	0.000158	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CD—lung cancer	1.1e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—lung cancer	1.1e-05	0.000156	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—lung cancer	1.09e-05	0.000155	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—lung cancer	1.09e-05	0.000154	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—lung cancer	1.08e-05	0.000153	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—lung cancer	1.08e-05	0.000153	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOA1—lung cancer	1.06e-05	0.000151	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—lung cancer	1.05e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—lung cancer	1.05e-05	0.000149	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—lung cancer	1.04e-05	0.000148	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—lung cancer	1.04e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—lung cancer	1.04e-05	0.000147	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—lung cancer	1.01e-05	0.000144	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—lung cancer	1.01e-05	0.000143	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—lung cancer	9.94e-06	0.000141	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MDM2—lung cancer	9.9e-06	0.00014	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RAF1—lung cancer	9.86e-06	0.00014	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—lung cancer	9.85e-06	0.000139	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1A—lung cancer	9.81e-06	0.000139	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—lung cancer	9.79e-06	0.000139	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—lung cancer	9.76e-06	0.000138	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KIT—lung cancer	9.7e-06	0.000137	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CG—lung cancer	9.7e-06	0.000137	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APC—lung cancer	9.7e-06	0.000137	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—NRAS—lung cancer	9.7e-06	0.000137	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MTOR—lung cancer	9.63e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CB—lung cancer	9.63e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGF—lung cancer	9.59e-06	0.000136	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—lung cancer	9.55e-06	0.000135	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—lung cancer	9.44e-06	0.000134	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EP300—lung cancer	9.33e-06	0.000132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK3—lung cancer	9.29e-06	0.000132	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—lung cancer	9.26e-06	0.000131	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—POMC—lung cancer	9.24e-06	0.000131	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—lung cancer	9.2e-06	0.00013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BRAF—lung cancer	9.12e-06	0.000129	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—lung cancer	9.08e-06	0.000129	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6R—lung cancer	9.01e-06	0.000128	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CREBBP—lung cancer	9e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—lung cancer	8.94e-06	0.000127	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—lung cancer	8.86e-06	0.000125	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—lung cancer	8.84e-06	0.000125	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—lung cancer	8.84e-06	0.000125	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—lung cancer	8.84e-06	0.000125	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—lung cancer	8.8e-06	0.000125	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—lung cancer	8.75e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NRAS—lung cancer	8.73e-06	0.000124	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—lung cancer	8.62e-06	0.000122	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—lung cancer	8.6e-06	0.000122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAP2K1—lung cancer	8.59e-06	0.000122	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CD—lung cancer	8.53e-06	0.000121	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—lung cancer	8.45e-06	0.00012	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—lung cancer	8.37e-06	0.000119	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK3—lung cancer	8.36e-06	0.000118	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—lung cancer	8.35e-06	0.000118	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1A—lung cancer	8.34e-06	0.000118	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—lung cancer	8.32e-06	0.000118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—lung cancer	8.13e-06	0.000115	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—lung cancer	8.12e-06	0.000115	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—lung cancer	7.96e-06	0.000113	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EP300—lung cancer	7.94e-06	0.000112	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—lung cancer	7.72e-06	0.000109	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—lung cancer	7.71e-06	0.000109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—lung cancer	7.67e-06	0.000109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MDM2—lung cancer	7.64e-06	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RAF1—lung cancer	7.62e-06	0.000108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—lung cancer	7.54e-06	0.000107	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—lung cancer	7.52e-06	0.000106	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—lung cancer	7.52e-06	0.000106	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—lung cancer	7.44e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CB—lung cancer	7.44e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTOR—lung cancer	7.44e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NRAS—lung cancer	7.42e-06	0.000105	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—lung cancer	7.15e-06	0.000101	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK3—lung cancer	7.11e-06	0.000101	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—lung cancer	7.1e-06	0.000101	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—lung cancer	6.92e-06	9.79e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—lung cancer	6.9e-06	9.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—lung cancer	6.9e-06	9.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—lung cancer	6.84e-06	9.69e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—lung cancer	6.83e-06	9.67e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—lung cancer	6.79e-06	9.62e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—lung cancer	6.76e-06	9.58e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—lung cancer	6.68e-06	9.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—lung cancer	6.66e-06	9.43e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—lung cancer	6.64e-06	9.41e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—lung cancer	6.46e-06	9.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	6.44e-06	9.12e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—lung cancer	6.43e-06	9.1e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—lung cancer	6.39e-06	9.05e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—lung cancer	6.39e-06	9.05e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—lung cancer	6.27e-06	8.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EP300—lung cancer	6.13e-06	8.68e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—lung cancer	6.11e-06	8.66e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—lung cancer	5.96e-06	8.44e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—lung cancer	5.87e-06	8.31e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—lung cancer	5.8e-06	8.22e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—lung cancer	5.75e-06	8.14e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRAS—lung cancer	5.73e-06	8.12e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—lung cancer	5.68e-06	8.04e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—lung cancer	5.64e-06	7.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK3—lung cancer	5.49e-06	7.78e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—lung cancer	5.43e-06	7.69e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—lung cancer	5.34e-06	7.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—lung cancer	5.22e-06	7.4e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—lung cancer	5.2e-06	7.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—lung cancer	4.93e-06	6.99e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—lung cancer	4.8e-06	6.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	4.53e-06	6.42e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—lung cancer	4.39e-06	6.21e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—lung cancer	4.19e-06	5.94e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—lung cancer	4.01e-06	5.68e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—lung cancer	3.7e-06	5.24e-05	CbGpPWpGaD
